Efficacy of Human Papillomavirus Vaccines for Recalcitrant Anogenital and Oral Warts
Human papillomavirus (HPV) vaccines are preventive measures to decrease HPV infection rates. Knowledge of their efficacy as treatment options for anogenital warts (AGWs) and oral warts (OWs) is limited. To evaluate the efficacy of HPV vaccinations in recalcitrant AGWs and OWs (lesions persisting mor...
Main Authors: | Giulia Ciccarese, Astrid Herzum, Gaetano Serviddio, Corrado Occella, Aurora Parodi, Francesco Drago |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-11-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/12/23/7317 |
Similar Items
-
Viral metagenomics updated the prevalence of human papillomavirus types in anogenital warts
by: Hui Xu, et al.
Published: (2019-01-01) -
HPV-associated anogenital condylomas: clinical-morphological aspects and therapy principles
by: N. M. Nazarova, et al.
Published: (2018-09-01) -
Incidence of anogenital warts in Liuzhou, south China: a comparison of data from a prospective study and from the national surveillance system
by: Feixue Wei, et al.
Published: (2017-01-01) -
Prospective Longitudinal Study of Dynamics of Human Papillomavirus 6 and 11 Infection in Anogenital Hairs and Eyebrows of Male Patients with Anogenital Warts and Age-Matched Controls
by: Vesna Tlaker, et al.
Published: (2024-02-01) -
Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT
by: Richard Gilson, et al.
Published: (2020-09-01)